RxDoctor Payments Data

Louis Rappoport, MD

Orthopaedic Surgery of the Spine · Phoenix, AZNPI 1497778740

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (55.0%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Globus Medical accounts for 80.0% of it on its own, with 13 other manufacturers making up the rest.

$236,018in general payments, 2019–2025

Across 486 payments — averaging $485.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$189K
  • Medtronic$39K
  • Mirus, LLC$2K
  • Osteocentric Technologies, Inc.$2K
  • Cerapedics Inc.$2K
  • Seaspine Orthopedics Corporation$629
  • plus $1K from 8 others
$2,809in research payments, 2019–2025

Across 3 payments — averaging $936.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Globus Medical$3K

What the payments were for

  • Royalty or licence$129,75155%
  • Consulting fees$34,80515%
  • Speaking & faculty fees$32,35014%
  • Travel & lodging$30,53113%
  • Food & beverage$8,4614%
  • Education$1210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$236,018 in reported general payments places this provider in the 80th percentile of 64 orthopaedic surgery of the spine providers in Arizona.

See all orthopaedic surgery of the spine providers in Arizona

Medicare billing

Part B allowed, 2024
$230,397
Medicare patients
172
Services billed
1,459

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen78$2,004
Oxycodone Hcl149$1,749
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen87$1,725
Gabapentin62$1,031
Diclofenac Sodium ErDiclofenac Sodium22$934
Cyclobenzaprine Hcl43$334
Tizanidine Hcl20$326
Pregabalin24$285
Zolpidem Tartrate26$177
Tramadol Hcl45$137
Methylprednisolone16$125

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →